Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Efficacy and Safety of Intranasal MSP-2017 (Etripamil) for the Conversion of PSVT to Sinus Rhythm

ClinicalTrials.gov ID: NCT02296190

Public ClinicalTrials.gov record NCT02296190. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 1, 2026, 9:29 AM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multi-Center, Placebo-Controlled, Dose-Ranging Phase 2 Electrophysiological Study of Intranasal Administration of MSP-2017 for the Conversion of Induced Paroxysmal Supraventricular Tachycardia (PSVT) to Sinus Rhythm

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to demonstrate the superiority of at least 1 dose of intranasal (IN) MSP-2017 (Etripamil) over placebo in terminating PSVT induced in an electrophysiology (EP) laboratory.

Study identification

NCT ID
NCT02296190
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
199 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 27, 2015 (Type not available)
Primary completion
Dec 2016 (Actual)
Completion
Dec 2016 (Actual)
Last update posted
Dec 30, 2020

2015 – 2016

United States locations

U.S. sites
26
U.S. states
14
U.S. cities
22
Facility City State ZIP Site status
Arizona Heart Rhythm Center Phoenix Arizona 85013 —
Mayo Clinic Arizona Phoenix Arizona 85054 —
Mercy General Hospital Sacramento California 95819 —
South Denver Cardiology Associates Littleton Colorado 80120 —
Medstar Washington Hospital Center Washington D.C. District of Columbia 20010 —
Memorial Hospital Jacksonville Jacksonville Florida 32216 —
Mayo Clinic Jacksonville Jacksonville Florida 32224 —
Northside Hospital St. Petersburg Florida 33709 —
University of South Florida Health South Tampa Center Tampa Florida 33606 —
Piedmont Atlanta Hospital Atlanta Georgia 30309 —
Emory University Hospital Atlanta Georgia 30322 —
Iowa Heart Center West Des Moines Iowa 50266 —
University of Kansas Medical Center Kansas City Kansas 66160 —
MedStar Health Research Institute Baltimore Maryland 21237 —
Mayo Clinic Rochester Minnesota 55902 —
Aultman Hospital Cardiology Clinical Trials Canton Ohio 44708 —
University of Cincinnati Medical Center Division of Cardiovascular Diseases Cincinnati Ohio 45267 —
ProMedica Toledo Hospital Toledo Ohio 43606 —
Great Lakes Medical Research, LLC Willoughby Ohio 44094 —
Black Hills Cardiovascular Research Rapid City South Dakota 57701 —
Texas Cardiac Arrhythmia Research Foundation Austin Texas 78705 —
Baylor St. Luke's Hospital Houston Texas 77030 —
Houston Methodist Hospital Houston Texas 77030 —
University of Virginia Medical Center Charlottesville Virginia 22908 —
Centra Stroobants Cardiovascular Center Lynchburg Virginia 24501 —
Sentara Norfolk General Hospital Norfolk Virginia 23507 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02296190, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 30, 2020 · Synced Nov 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02296190 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →